Use of luteal estrogen supplementation in normal responder patients treated with fixed multidose GnRH antagonist: a prospective randomized controlled study

Fertility and Sterility

Volumn 89, Issue 6, 2008, Pages 1827-1830

  Ceyhan, S Temel ^a   Basaran, Mustafa ^b   Kemal Duru, Namik ^a   Yilmaz, Ali ^a   Göktolga, Ümit ^a   Baser, Iskender ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADERM TTS 100; ESTROGEN; GONADORELIN ANTAGONIST; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HORMONAL THERAPY; HUMAN; LUTEAL PHASE; MULTIPLE CYCLE TREATMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; CORPUS LUTEUM; ESTRADIOL; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES;

EID: 44349148345     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.08.029     Document Type: Article

References (17)

1. Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 5 (1990) 357-376
2. Engel J.B., Griesinger G., Schultze-Mosgau A., Felberbaum R., and Diedrich K. GnRH agonists and antagonists in assisted reproduction: pregnancy rate. Reprod Biomed Online 13 (2006) 84-87
3. Shapiro D.B. An overview of GnRH antagonists in infertility treatments. Introduction. Fertil Steril 80 Suppl 1 (2003) S1-S7 discussion S32-4
4. Lukaszuk K., Liss J., Lukaszuk M., and Maj B. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 83 (2005) 1372-1376
5. Tavaniotou A., and Devroey P. Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reprod Biomed Online 13 (2006) 326-330
6. Fatemi H.M., Kolibianakis E.M., Camus M., Tournaye H., Donoso P., Papanikolaou E., et al. Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. Hum Reprod 21 (2006) 2628-2632
7. Laufer N., Navot D., and Schenker J.G. The pattern of luteal phase plasma progesterone and estradiol in fertile cycles. Am J Obstet Gynecol 143 (1982) 808-813
8. Pritts E.A., and Atwood A.K. Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Hum Reprod 17 (2002) 2287-2299
9. Farhi J., Weissman A., Steinfeld Z., Shorer M., Nahum H., and Levran D. Estradiol supplementation during the luteal phase may improve the pregnancy rate in patients undergoing in vitro fertilization-embryo transfer cycles. Fertil Steril 73 (2000) 761-766
10. Diedrich K., Diedrich C., Santos E., Zoll C., al-Hasani S., Reissmann T., et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Hum Reprod 9 (1994) 788-791
11. D'Amato G., Caroppo E., Pasquadibisceglie A., Carone D., Vitti A., and Vizziello G.M. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years. Fertil Steril 81 (2004) 1572-1577
12. de Jong D., Macklon N.S., Eijkemans M.J., Mannaerts B.M., Coelingh Bennink H.J., and Fauser B.C. Dynamics of the development of multiple follicles during ovarian stimulation for in vitro fertilization using recombinant follicle-stimulating hormone (Puregon) and various doses of the gonadotropin-releasing hormone antagonist ganirelix (Orgalutran/Antagon). Fertil Steril 75 (2001) 688-693
13. Weiss J.M., Oltmanns K., Gurke E.M., Polack S., Eick F., Felberbaum R., et al. Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. Eur J Endocrinol 144 (2001) 677-685
14. Latouche J., Crumeyrolle-Arias M., Jordan D., Kopp N., Augendre-Ferrante B., Cedard L., et al. GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study. Endocrinology 125 (1989) 1739-1741
15. Minaretzis D., Alper M.M., Oskowitz S.P., Lobel S.M., Mortola J.F., and Pavlou S.N. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Am J Obstet Gynecol 172 (1995) 1518-1525
16. Tarlatzis B.C., and Kolibianakis E.M. Direct ovarian effects and safety aspects of GnRH agonists and antagonists. Reprod Biomed Online 5 Suppl 1 (2002) 8-13
17. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril 73 (2000) 314-320